Alcaftadine
Who holds supplier records for Alcaftadine? 5 organisations hold a current record for Alcaftadine: an active US FDA Type II Drug Master File. A further 1 organisation has only historical (inactive) DMF filings. Recorded organisation countries for current records: India (3), Switzerland (1) and Spain (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Alcaftadine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/alcaftadine
Reading the evidence
- 5 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
3 of the 5 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 3 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Alcaftadine expires 23 Dec 2027. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (5)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Alcaftadine. Country is the organisation's recorded country, not necessarily the manufacturing site.
- APICORE PHARMACEUTICALS PRIVATE LIMITEDIndiaActive DMF 32382 · latest filing Jan 2018
- CILAG AGSwitzerland Company GMP cert on recordActive DMF 20066 · latest filing Dec 2006
- CURIA SPAIN SAUSpain Company GMP cert on recordActive DMF 27982 · latest filing Feb 2014
- MSN Laboratories Private LimitedIndia Company GMP cert on recordActive DMF 28932 · latest filing Feb 2015
- Neuland Laboratories LimitedIndiaActive DMF 28277 · latest filing May 2014
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (1)
Organisations whose Type II DMFs for Alcaftadine are no longer active. These show a past filing, not current supply.
Show all 1 historical record
- India · Inactive DMF 27559 · filed Dec 2013
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (3 listed products contain Alcaftadine). The latest listed patent expires 23 Dec 2027. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Alcaftadine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1201747).
Chemical identity
- IUPAC name
- 11-(1-methylpiperidin-4-ylidene)-5,6-dihydroimidazo[2,1-b][3]benzazepine-3-carbaldehyde
- Canonical SMILES
- CN1CCC(=C2C3=CC=CC=C3CCN4C2=NC=C4C=O)CC1
- InChIKey
- MWTBKTRZPHJQLH-UHFFFAOYSA-N
- Synonyms
- Alcaftadina, Alcaftadine, Lastacaft, R 89674, R-89674, alcaftadinum, R89674, CHEBI:71023, RefChem:57993, S01GX11, Alcaftadine-d3, Lastacaft (TN)
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Histamine-1 Receptor Antagonist
- Mechanism of action
- Histamine H1 Receptor Antagonists
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Alcaftadine?
5 organisations hold an active US FDA Type II Drug Master File or a CEP for Alcaftadine: APICORE PHARMACEUTICALS PRIVATE LIMITED (India), CILAG AG (Switzerland), CURIA SPAIN SAU (Spain), MSN Laboratories Private Limited (India) and Neuland Laboratories Limited (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Alcaftadine Drug Master Files are active?
APICORE PHARMACEUTICALS PRIVATE LIMITED (DMF 32382), CILAG AG (DMF 20066), CURIA SPAIN SAU (DMF 27982), MSN Laboratories Private Limited (DMF 28932) and Neuland Laboratories Limited (DMF 28277). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Alcaftadine records mean?
1 organisation has only inactive Type II DMFs for Alcaftadine. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does the FDA Orange Book list patents for products containing Alcaftadine?
Yes. The latest patent listed for an approved US product containing Alcaftadine expires 23 Dec 2027, across 3 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Alcaftadine supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Alcaftadine?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.